ATGGX | RERCX | ATGGX / RERCX | |
Total Expense Ratio | 1.02 | 1.12 | 91% |
Annual Report Gross Expense Ratio | 1.02 | 1.12 | 91% |
Fund Existence | 8 years | 23 years | - |
Gain YTD | 14.848 | 15.874 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.72B | 135B | 2% |
Annual Yield % from dividends | 0.62 | 0.51 | 122% |
Returns for 1 year | 9.15 | 7.73 | 118% |
Returns for 3 years | 26.23 | 23.53 | 111% |
Returns for 5 years | 4.83 | 11.09 | 44% |
Returns for 10 years | N/A | 29.65 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWHFX | 23.68 | 0.33 | +1.41% |
Schwab Health Care | |||
VPRAX | 26.61 | N/A | N/A |
VY® T. Rowe Price Capital Apprec R6 | |||
NWHUX | 33.64 | -0.15 | -0.44% |
Nationwide Bailard Tech & Sci Instl Svc | |||
BMSFX | 15.05 | -0.07 | -0.46% |
MFS Blended Research Mid Cap Eq A | |||
BERCX | 17.68 | -0.12 | -0.67% |
Carillon Chartwell Mid Cap Value I |